This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lai ZQ, Fu Y, Liu JW, Zhang HJ, Zhang H, Liang NP, et al. The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study. Hypertens Res. 2023. https://doi.org/10.1038/s41440-023-01503-8.
Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M. Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology. 2003;227:401–6.
Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof‐of‐principle trial. J Clin Hypertens. 2020;22:1618–26.
Dong H, Zou Y, He J, Deng Y, Chen Y, Song L, et al. Superselective adrenal arterial embolization for idiopathic hyperaldosteronism:12‐month results from a proof‐of‐principle trial. Catheter Cardiovasc Interv. 2021;97:976–81.
Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation. 2021;144:580–2.
Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistré A, et al. The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int J Cardiol Hypertens. 2020;5:100029.
Rossi GP. Primary aldosteronism: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:2799–2811.
Marzano L, Kazory A, Husain-Syed F, Ronco C. Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: a systematic review and meta-analysis. Clin Endocrinol. 2023;99:17–34.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cabrelle, G., Zanon, C. & Rossi, G.P. Re: The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study. Hypertens Res (2024). https://doi.org/10.1038/s41440-024-01664-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41440-024-01664-0